Jane Street’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Other funds holding BBC
KCP
MCM
QCM
APW
FTUS
GAA
Jane Street's BBC Position: Q1 2026 in Review
Jane Street reduced its Virtus Biotech Clinical Trials ETF (BBC) stake by 4.5% in Q1 2026, selling an estimated $14.5K and leaving 7,575 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #9134.
Jane Street first reported a position in BBC in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.07M in Q2 2015. 20 funds tracked by Wall St. Rank hold BBC as of Q1 2026.
- Jane Street held 7,575 shares of Virtus Biotech Clinical Trials ETF worth $315K as of Q1 2026.
- Jane Street sold 353 Virtus Biotech Clinical Trials ETF shares in Q1 2026, an estimated $14.5K.
- Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9134 holding.
- Jane Street first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2014 and has held it in 20 quarters since.
- Jane Street's Virtus Biotech Clinical Trials ETF position peaked at $2.07M in Q2 2015.
- 20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.